| 000 | 01622 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250512014611.0 | ||
| 264 | 0 | _c19890706 | |
| 008 | 198907s 0 0 eng d | ||
| 022 | _a0887-6924 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGastl, G | |
| 245 | 0 | 0 |
_aComparison of clinical efficacy and toxicity of conventional and optimum biological response modifying doses of interferon alpha-2C in the treatment of hairy cell leukemia: a retrospective analysis of 39 patients. _h[electronic resource] |
| 260 |
_bLeukemia _cJun 1989 |
||
| 300 |
_a453-60 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xblood |
| 650 | 0 | 4 |
_aBiopterins _xanalogs & derivatives |
| 650 | 0 | 4 |
_aBone Marrow _xpathology |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferon Type I _xadministration & dosage |
| 650 | 0 | 4 |
_aLeukemia, Hairy Cell _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeopterin |
| 650 | 0 | 4 |
_aNeutropenia _xetiology |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aThrombocytopenia _xetiology |
| 700 | 1 | _aWerter, M | |
| 700 | 1 | _aDe Pauw, B | |
| 700 | 1 | _aNerl, C | |
| 700 | 1 | _aAulitzky, W | |
| 700 | 1 | _avon Lüttichau, I | |
| 700 | 1 | _aTilg, H | |
| 700 | 1 | _aThaler, J | |
| 700 | 1 | _aLang, A | |
| 700 | 1 | _aAbbrederis, K | |
| 773 | 0 |
_tLeukemia _gvol. 3 _gno. 6 _gp. 453-60 |
|
| 999 |
_c2730939 _d2730939 |
||